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the homolog that it replaced, the authors engineered the 
foreign psychrophilic gene under the control of a host 
promoter and expressed it using host machinery [Figure 1]. 
The rate of mutation that will revert back the TS strain 
to a temperature-resistant strain was also assessed by the 
authors on essential gene such as ligASf, ligACp, ligAPh, 
hemCCp, pyrGCp, dnaKCp, murGCp, dnaKSf, fmtCp, ftsZCp, cmkCp, 
and tyrSCp.[18]
To check the TS viability of the TS F. novicida carrying 
either ligACp, ligAPh or dnaKCp essential genes, the strains were 
broth cultured at restrictive temperatures. Results showed 
an identical growth rate to that of wild-type F. novicida. 
Since F. novicida is a facultative intracellular pathogen, the 
growth rate of TS F. novicida in infected macrophages-
like cell line (    J774 cell line) was examined to check the 
TS viability. The results showed a decline in the number 
of viable TS F. novicida in the J774 cell line at restrictive 
temperature, indicating the temperature sensitivity of TS F. 
novicida carrying either ligACp, ligAPh and dnaKCp essential 
genes. Moreover, TS F. novicida carrying either ligACp or 
ligAPh showed a growth rate similar to wild-type F. novicida at 
permissive temperatures within infected J774 cells, whereas 
strain carrying dnaKCp showed a poor growth indicating the 
gene-specific variability among the TS strains created.[18]
To determine the pathogenic effect caused by   
TS F. novicida on infected cultured J774 cells, the cells were 
microscopically examined for their viability. It was found 
that the J774 cell infected with TS F. novicida remained 
viable on shifting to restrictive temperature when compared 
to control ( J774 cells infected with wild-type F. novicida), 
indicating the nonpathogenic nature of engineered   
TS F. novicida strains.[18]
In order to test the capacity of TS F. novicida to grow only 
in cooler body regions and not in warmer body core, rats 
and mice were infected with the TS F. novicida at the base 
of tail. It was observed that TS F. novicida with restrictive 
temperatures at or below 37°C were not found in spleen 
Evolutionarily Conserved 
Essential Genes from Arctic 
Bacteria: A Tool for Vaccination
Sir,
Due to advancement in various molecular biological 
techniques, several indispensable evolutionarily conserved 
essential genes (genes that are necessary for viability of 
the living organisms) have been identified over the past 
decades among various groups of bacteria.[1-3] Moreover, 
the amino acid sequences of some of these essential genes 
were highly conserved across various classes of bacteria 
such as thermophiles (heat-loving) and psychrophiles 
(cold-loving). However, some of the product of essential 
genes of psychrophiles have been adapted to the cold 
environments for millions to billions of years[4-6] thus 
making these bacteria temperature-sensitive (TS), reduced 
viability at higher temperatures. In accordance with the 
above mentioned facts, the human body temperature 
varies depending upon the body parts, temperature of the 
skin varies between 32 and 36°C whereas the body core is 
about 37–42°C.[7,8] Over decades, attempts have been made 
to develop TS bacterial strains and viral strains,[9-12] yet 
bacterial strains were not adapted for human vaccination,[13] 
for example, the TS version of Yersinia pestis[14] and because 
of their reversion this strain was not further developed.  [13] 
Further, small numbers of TS bacterial strain vaccines 
(developed by chemical mutagenesis) were developed for 
veterinary use; but it is uncertain whether the TS nature 
is primary attenuating phenotype or merely a coincidental 
phenotype.[13] In the following work, Duplantis and 
colleagues have successfully transformed mesophilic 
pathogenic bacteria to a TS bacterial strain using essential 
genes from psychrophile and provide evidences for a 
successful vaccination strategy developed using such TS 
bacterial strain. The highlight, in the following work, is 
provided by the concept of using temperature adapted 
essential orthologue genes from psychrophile to develop 
the TS non-pathogenic version of bacterial strains.
In this study, the authors chose pathogenic mesophile 
Francisella tularensis subsp. novicida (F. novicida), maximum 
growth temperature is about 45°C, as host to transfer 
essential genes from a psychrophile Colwellia psychrerythraea, 
maximum growth temperature is about 19°C. Strains of 
F. tularensis is highly virulent to mice but also known to 
cause zoonotic disease in humans.[15] Here, the selection 
of host and donor species was based on the similar G + C 
contents of these species.[16,17] In order to maximize the 
chance that the foreign gene is expressed identically to 
Figure 1: Flowchart representing the transfer of essential gene from a 
psychrophilic bacterium to a mesophilic bacterium resulting in formation 
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whereas F. novicida with restrictive temperature above 37°C 
were detected in spleen (control), indicating the inefficiency 
of TS F. novicida strains to proliferate at body core organs. 
Moreover, viable TS F. novicida were found at the site of 
infection even after 3   days of injection, indicating the 
capacity of TS F. novicida to survive at cool body parts. 
These results were further validated by injecting the TS F. 
novicida into the fleshy part of mouse ears.[18]
To check whether the persistence of TS F. novicida at 
cool body parts induce protective immunity, mice were 
challenged with intranasal infection of wild-type F. novicida 
after 21 days of vaccination (injection of TS F. novicida 
carrying either ligACp, ligAPh or dnaKCp ) at the base of the tail. 
Using organ bacterial burden, morbidity and weight loss 
as measures of protection, it was found that TS F. novicida 
protected the host animal against the challenge caused 
by wild-type F. novicida [Figure 2]. It was also found that 
strains carrying dnaKCp showed greater dissemination and 
least protection, indicating the null role of dissemination 
in immune stimulation.[18]
Furthermore the effect of psychrophilic ligA was also 
examined in another Gram-negative bacterium, Salmonella 
enterica. It was found that psychrophilic ligA rendered 
the organism TS, indicating that this methodology can 
be applied to numerous important pathogens such as 
Salmonella thyphi, Escherichia coli, Yersinia pestis etc. Moreover, 
a codon-optimized version of ligACp (deleting most of the 
ligACp ) also made Mycobacterium smegmatis TS, indicating 
the functional ability of ligACp product in a Gram-positive 
lineage bacterium.[18]
The technology described in this work by the authors holds 
good not only to make live TS bacterial vaccines (known 
to be efficacious for protection against diseases that need 
cell-mediated immunity) but also in development of killed 
whole-cell or subunit vaccine and in development of TS 
version of dangerous bacterial pathogens which can be used 
to study their biochemical and pathological characteristics 
without physical containments.[18] Eventhough the Mother 
Nature has provided with hundreds of evolutionary 
conserved essential genes, careful selection of the essential 
gene from psychrophilic species is required to prevent 
the transformation of genetically engineered TS strains 
back to temperature-resistant strains through mutations. 
Technology developed by Duplantis et al. provides the 
way for engineering other pathogenic bacteria, so that they 
can be used as vaccines. However successful clinical trials, 
using TS bacterial strain for protection against bacterial 
pathogens, and experimentation will provide the way for 
the use of this technology for the welfare of humanity.
Shanmugam MM,   
Parasuraman S1
Departments of Anatomy and 1Pharmacology, Jawaharlal 
Institute of Postgraduate Medical Education and Research, 
Puducherry, India 




1.  Glass JI, Assad-Garcia N, Alperovich N, Yooseph S, Lewis MR, Maruf M, 
et al. Essential genes of minimal bacterium. Proc Natl Acad Sci U S A 
2006;103:425-30.
2.  Sassetti CM, Boyd DH, Rubin EJ. Comprehensive identification of 
conditionally essential genes in mycobacteria. Proc Natl Acad Sci U S A 
2001;98:12712-7.
3.  Thanassi JA, Hartman-Neumann SL, Dougherty TJ, Dougherty BA, 
Pucci MJ. Identification of 113 conserved essential genes using a high-
throughput gene disruption system in Streptococcus pneumonia. Nucleic Acids 
Res 2002;30:3152-62.
4.  Marx JC, Blaise V, Collins T, D’Amico S, Delille D, Gratia E, et al. A 
perspective on cold enzymes: Current knowledge and frequently asked 
question. Cell Mol Biol (Noisy-le-grand). 2004;50:643-55.
5.  Georlette D, Damien B, Blaise V, Depiereux E, Uversky VN, Gerday C, 
et al. Structural and functional adaptations to extreme temperatures in 
psychrophilic, mesophilic and thermophilic DNA ligases. J Biol Chem 
2003;278:37015-23.
6.  Gianese G, Argos P, Pascarella S. Structural adaptation of enzymes to low 
temperatures. Protein Eng 2001;14:141-8.
7.  Benzinger TH. Heat regulation: Homeostasis of central temperature in 
man. Physiol Rev 1969;49:671-759.
8.  Greiner JG, Clegg ME, Walsh ML, White MD. No effect of skin 
temperature on human ventilation response to hypercapnia during light 
Figure 2: Flowchart indicating the process of vaccination and 
subsequent protection against wild-type F. novicida (lane 2) in mouse, 
whereas showing more organ burden caused in non-vaccinated mouse 
(lane 1), due to infection with wild-type F. novicida.Journal of Young Pharmacists Vol 4 / No 1  57
Letters to the Editor
exercise with a normothermic core temperature. Eur J Appl Physiol 
2010;109:109-15.
9.  Chapin M, Dubes GR. Cold-adapted genetic variants of polio viruses. 
Science 1956;124:586-7.
10.  Maassab HF, De Borde DC. Development and characterization of clod-
adapted viruses for use as live virus vaccines. Vaccine 1985;3:355-69.
11.  Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, 
et al. Live attenuated versus inactivated influenza vaccine in infants and 
young children. N Engl J Med 2007;356:685-96.
12.  Chen Z, Aspelund A, Kemble G, Jin H. Molecular studies of temperature-
sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor 
virus for live attenuated influenza FluMist vaccines. Virology 2008;380:354-62.
13.  Duplantis BN, Bosio CM, Nano FE. Temperature-sensitive bacterial 
pathogens generated by the substitution of essential genes from cold-loving 
bacteria: Potential use as live vaccines. J Mol Med 2011;89:437-44.
14.  Munier-Lehmann H, Chenal-Francisque V, Ionescu M, Christova P, Foulon J, 
Carniel E, et al. Relationship between bacterial virulence and nucleotide 
metabolism: A mutation in the adenylate kinase gene renders Yersinia Pestis 
avirulent. J Biochem 2003;373:515-22.
15.  Oyston PC. Francisella tularensis: Unreavelling the secrets of an intracellular 
pathogen. J Med Microbiol 2008;57:921-30.
16.  Larsson P, Oyston PC, Chain P, Chu MC, Duffield M, Fuxelius HH, et al. 
The complete genome sequence of Francisella tularensis, the causative agent 
of tularemia. Nat Genet 2005;37:153-9.
17.  Methe BA, Nelson KE, Deming JW, Momen B, Melamud E, Zhang X, et al. 
The psychrophilic lifestyle as revealed by the genome sequence of Colwellia 
psychrerythraea 34H genomic and proteomic analyses. Proc Natl Acad Sci U 
S A 2005;102:10913-8.
18.  Duplantis BN, Osusky M, Schmerk CL, Ross DR, Bosio CM, Nano 
FE. Essential genes from Arctic bacteria used to construct stable, 
temperature-sensitive bacterial vaccines. Proc Natl Acad Sci U S A 
2010;107:13456-60.
Access this article online
Quick Response Code:
Website:  
www.jyoungpharm.in
DOI:  
10.4103/0975-1483.93569